download the program - milken institute

PROGRAM | JANUARY 2014 | ATLANTA

THE SUMMITon Public Health and Prosperity

Building innovative partnerships to advance CDC’s 24/7 life-saving work to protect us all.

Since 1995, the CDC Foundation has provided more than $400 million to support CDC’s work, launched 700 programs around the world and built a network of individuals and

organizations committed to supporting CDC and public health.

www.cdcfoundation.org

OUR MISSIONS

When we mobilize the right people around powerful ideas, there’s no limit to the progress we can achieve.

Our mission is to improve lives around the world by advancing innovative economic and policy solutions that create jobs,

widen access to capital and enhance health.

www.milkeninstitute.org

Welcome!

This first-of-its-kind Summit on Public Health and Prosperity at the Centers for Disease Control and Prevention convenes what might be considered a board of directors of American public health. As you look at the listing of your fellow participants, note that they represent a broad cross-section of leaders from industry, government, foundations, universities, philanthropy and public policy. They share not only a dedication to helping people but also a capacity to drive change.

The human and social value of safeguarding health is clear. It’s also important to business and to international prosperity. Over the past two centuries, advances in public health and medical research have accounted for as much as half of all economic growth. CDC has been a global leader in many of those advances. Because disease knows no borders, the agency is directly engaged in efforts around the world. Supporting them is the CDC Foundation, which was established by Congress as an independent, nonprofit organization to help CDC make our world healthier and safer. Recognizing that health security equals a healthy economy, the Foundation connects CDC with private-sector businesses, philanthropies and individuals to do more, faster.

For nearly a quarter century, the Milken Institute has sought solutions to major global challenges through a combination of rigorous research and events that convene a network of influential decision-makers from the private and public sectors. The Milken Institute Global Conference brings more than 3,500 of these leaders from some 50 nations to Los Angeles each spring to help transform ideas into action; and the annual Partnering for Cures conference hosted by the Institute’s FasterCures center spotlights innovative and collaborative solutions that are transforming the medical research system. In that spirit, this Atlanta Summit is designed to do for public health what the Institute’s 2012 Celebration of Science did in reaffirming the importance of bioscience.

We wish you a productive and stimulating experience and invite you to join with our two organizations in a mutual quest to protect the health of populations everywhere.

Michael Milken Chairman The Milken Institute

Charles Stokes President and CEO CDC Foundation

2

SUMMIT NOTES

Name Badge IdentificationFor security reasons, you are required to wear your name badge during the event.

Program ChangesPlease note that there may have been changes to the program, speakers and participants since you registered.

Reserved SeatingSeating at the Thursday dinner and Friday lunch is assigned. Additionally, some activities in Auditorium A may include reserved seating.

Mobile DevicesAs a courtesy to our panelists and guests, please be sure to set your cell phones and devices to silent mode.

Session SlidesSlides presented at each panel will be available on the Milken Institute website after the conference.

ATTENTION ATLANTA SUMMIT ATTENDEES

The CDC Foundation / Milken Institute Atlanta Summit on Public Health and Prosperity is being videotaped and/or audiotaped for rebroadcast over the air, on the Internet or otherwise. As a member of the audience, you may be recorded. By attending this program, you grant permission to the CDC Foundation and Milken Institute to use your appearance, likeness and/or voice in connection with any photographing, videotaping/audiotaping and/or rebroadcast of the program.

3

THE SUMMIT PROGRAM

6:00 PM – 9:00 PM

MILKEN INSTITUTE RECEPTION AND DINNER

7:00 AM – 8:30 AM

REGISTRATION Visitor’s Center Lobby

7:30 AM – 8:30 AM

CONTINENTAL BREAKFAST AND TOURS OF THE CDC MUSEUM

Atrium

The St. Regis Atlanta

THURSDAY, JANUARY 30

FRIDAY, JANUARY 31

Global Communications Center, CDC Campus

4

MILKEN INSTITUTE & CDC FOUNDATION

8:40 AM – 9:00 AMP

LE

NA

RY WELCOME REMARKS BY

CDC DIRECTOR TOM FRIEDEN AND MILKEN INSTITUTE CHAIRMAN MIKE MILKEN

Auditorium A

9:00 AM – 9:50 AM

PL

EN

AR

Y GLOBAL HEALTH SECURITY: CONTAINING THREATS WORLDWIDE

Auditorium A

Today, a health threat anywhere is a threat everywhere. New microbes emerge and spread quickly with international trade and travel. Drug resistance is increasing, and bioterrorism could strike any nation. In all of these scenarios, CDC is America’s front line of defense. This panel will explore how the agency does its crucial work and also feature clips from the movie “Contagion,” which tracks the course of a devastating global outbreak through the eyes of CDC disease detectives. While the script is fiction, it reflects very real risks. There were 50–100 million deaths worldwide from the 1918 flu pandemic, and new and rapidly changing strains of flu pose a similar threat today. Yet, a future pandemic could do more than devastate our nation’s health. It could also jeopardize the bonds that hold our society together and cause lasting economic damage.

MODERATOR:

Gary Cohen, Executive Vice President, BD (Becton, Dickinson and Company)

SPEAKERS:

Larry Brilliant, President and CEO, Skoll Global Threats Fund

Ali Khan, U.S. Assistant Surgeon General (Ret.); Director, Office of Public Health Preparedness & Response, CDC

Anne Schuchat, U.S. Assistant Surgeon General; Director, National Center for Immunization and Respiratory Diseases, CDC

SUMMIT AGENDA

5

10:00 AM – 10:50 AMB

RE

AK

OU

T GOVERNMENT, INDUSTRY AND A HEALTHIER FUTURE: A LEADERSHIP FORUM

Distance Learning AuditoriumInvitation Only

This session provides an open forum for members of Congress, senior executives and major philanthropists to discuss the public health issues that affect their constituents, their companies, their causes and the nation’s health. Mike Milken and Tom Frieden will lead the discussion.

MODERATORS:

Mike Milken, Chairman, Milken Institute

Tom Frieden, Director, CDC

SPEAKERS:

Sanford D. Bishop Jr., U.S. Representative, Georgia

Robert P. Casey Jr., U.S. Senator, Pennsylvania

Vincent Forlenza, Chairman, President and CEO, BD (Becton, Dickinson and Company)

Robert Hugin, CEO and Chairman, Celgene; Chairman, PhRMA

Jack Kingston, U.S. Representative, Georgia

Sue Siegel, CEO, healthymagination, GE

6


10:00 AM – 10:50 AMB

RE

AK

OU

T THE ART OF ALIGNMENT – NONPROFIT STRATEGIES FOR IMPROVING PUBLIC HEALTH

Auditorium A

For more than a century, America’s universities and charitable foundations have been at the forefront of innovations that increased quality of life and extended longevity. Today more than ever, the nonprofit sector plays a crucial role in improving public health in the nation and around the world. But philanthropies, universities, and public charities vary greatly in their cultures, views, and capacity to effect meaningful change. So how can these disparate organizations coordinate their efforts for the greater good? That’s the art of alignment. We’ll examine how the most successful philanthropies and universities find common ground to change the world.

MODERATOR:

Charles Stokes, President and CEO, CDC Foundation

SPEAKERS:

Anna Barker, Director, Transformative Healthcare Knowledge Networks and Co-Director, Complex Adaptive Systems Initiative, Arizona State University

Lynn Goldman, Dean, George Washington University School of Public Health

Larry Jameson, Senior Vice President, University of Pennsylvania for the Health System; Dean, University of Pennsylvania Medical School

John Lange, Senior Fellow, Global Health Diplomacy, United Nations Foundation; former U.S. Ambassador to Botswana

James Marks, Senior Vice President, Robert Wood Johnson Foundation

SUMMIT AGENDA

7

11:00 AM – 11:20 AM

BRIEF REPORTS ON BREAKOUT SESSIONS

MODERATORS:



Charles Stokes, President and CEO, CDC Foundation

Auditorium A

11:20 AM – 12:10 PM

PL

EN

AR

Y A RACE WE CAN’T AFFORD TO LOSE: OUTSMARTING SUPERBUGS

Auditorium A

No one should go to the doctor to get well and instead get a life-threatening infection, but one in every 20 hospitalized patients contracts an infection caused by medical care, resulting in 99,000 deaths and up to $45 billion in excess medical costs each year. Likewise, Americans count on a safe food supply, but CDC estimates that 48 million people get sick and 3,000 die from contaminated food annually with costs up to $77 billion. And antibiotics are miracle drugs that most of us rely on, but bacteria are devising new ways to outsmart them, as in the case of drug-resistant tuberculosis. Breakthroughs in advanced molecular detection (AMD) are rendering these and other challenges imminently more solvable. Not long ago, it took months to sequence – and months more to interpret – a tiny part of a genome. Now, through AMD, a microchip can do all of this in a matter of hours. How do we harness scientific advances to address these national and global health challenges that result from bio-terror, bio-error and newly emerging superbugs?

MODERATOR:

Larry Brilliant, President and CEO, Skoll Global Threats Fund

SPEAKERS:

Beth Bell, Director, National Center for Emerging and Zoonotic Infectious Diseases, CDC

Victoria Nahum, Executive Director, Safe Care Campaign

Lance Price, Professor, Environmental and Occupational Health, George Washington University

Andrew von Eschenbach, President, Samaritan Health Initiatives; former Commissioner, U.S. Food and Drug Administration; former Director, National Cancer Institute

8


12:20 PM – 2:00 PMP

LE

NA

RY Lunch Program

REMARKS BY CHARLES STOKES, PRESIDENT, CDC FOUNDATION

PANEL — PUBLIC HEALTH PARTNERSHIPS: INDUSTRY, UNIVERSITIES, PHILANTHROPY AND GOVERNMENT

Auditorium B

The public health ecosystem includes pharmaceutical and biotechnology companies, academic medical research centers, major charitable foundations, local and state health departments, the World Health Organization, NGOs, schools of public health, national health agencies around the world and, at its very center, the U.S. Centers for Disease Control and Prevention. Not one of these entities can achieve its mission independent of the others. It is a complex and highly effective web of dedicated scientists who stand between all of us and global disaster. The experts on this panel will explore how to make that web even more effective and efficient, so that the past century’s remarkable advances in health and longevity continue for future generations.

MODERATOR:


SPEAKERS:


Freda Lewis-Hall, Executive Vice President and Chief Medical Officer, Pfizer Inc.

Trevor Mundel, President, Global Health Program, Bill & Melinda Gates Foundation

Carmen Puliafito, Dean, Keck School of Medicine, University of Southern California

Judith Rodin, President, The Rockefeller Foundation

SUMMIT AGENDA

9

2:10 PM – 3:00 PMB

RE

AK

OU

T THE ECONOMIC BURDEN OF CHRONIC DISEASE: PREVENTING THE PREVENTABLE

Distance Learning Auditorium

Most analyses of chronic illness focus on direct medical expenses, but that approach shows only a small part of the picture. Missing are the drag on long-term economic growth and the impact on productivity (largely through absenteeism and “presenteeism,” in which employees show up but underperform). In 2007, the Milken Institute took a comprehensive view in “An Unhealthy America,” which forecast the economic benefits the nation could reap by “containing the containable” costs of seven common chronic diseases. By mid-century, the report estimated, the U.S. economy could be $5.7 trillion smaller if we don’t change course. In conjunction with this Summit, the Institute re-ran the numbers to determine whether we’re making progress. Chief Research Officer Ross DeVol joins a panel focused on strategies that communities, businesses and nonprofits are implementing to create a healthier America.

MODERATOR:

Margaret Anderson, Executive Director, FasterCures

SPEAKERS:

Steven Burd, CEO, Burd and Company; former Chairman and CEO, Safeway Inc.

Ross DeVol, Chief Research Officer, Milken Institute

David Heber, Professor and Director, UCLA Center for Human Nutrition

David Schlanger, CEO, WebMD

Ken Thorpe, Chairman, Emory Partnership to Fight Chronic Disease; Professor and Chair, Department of Health Policy and Management, Emory University

10


2:10 PM – 3:00 PMB

RE

AK

OU

T TALES FROM THE FRONT LINES: HOW CDC’S ELITE DISEASE DETECTIVES RISK THEIR LIVES TO PROTECT YOURS

Auditorium A

CDC is America’s 9-1-1 responder to health security threats. When the call comes in, members of the elite Epidemic Intelligence Service (EIS) ship out at a moment’s notice to wherever they’re needed – from Bakersfield to Botswana to Bhutan. Whether applied to an infectious disease, deliberate attack or other emergency, CDC’s expertise in preparedness, rapid detection and response saves lives and safeguards the world. Indeed, the agency’s most important achievements are the outbreaks that didn’t happen and the diseases that were stopped before they crossed our borders. Those lives protected often can’t be counted, and they don’t make the news. Nor do the stories of the brave men and women who carry out that work. You’ll hear them today.

MODERATOR:

Mike Bell, Deputy Director, Division of Healthcare Quality Promotion, CDC

SPEAKERS:

Robyn Neblett Fanfair, Medical Epidemiologist, CDC

Barbara Knust, Epidemiologist, CDC

Andrea McCollum, Epidemiologist, CDC

Jennifer McQuiston, Veterinary Medical Officer, CDC

Rachel Smith, Medical Epidemiologist, CDC

SUMMIT AGENDA

11

3:10 PM – 3:55 PMP

LE

NA

RY THE BUSINESS CASE FOR PUBLIC HEALTH Auditorium A

The doubling of life expectancy globally during the 20th century is perhaps the greatest achievement of our civilization. Improved health has reduced suffering immeasurably, and it accounts for an estimated half of all economic growth since 1900. Public health programs to ensure clean water and food, minimize the impact of pandemics and improve vehicle safety have played vital roles. Corporate wellness programs have also resulted in a healthier, more productive workforce that uses less sick leave and is more likely to stay employed. Companies and other organizations that have implemented effective wellness programs have collectively saved billions of dollars in health expenses while reducing costs of recruitment and training. Just returning the American population to its average weight of two decades ago could save at least $1 trillion a year. This panel will discuss what has worked and why.

MODERATOR:


SPEAKERS:

Steven Burd, CEO, Burd and Company; former Chairman and CEO, Safeway Inc.

Bob Hugin, CEO and Chairman, Celgene Corporation; Chairman, PhRMA

Rajiv Kaul, Portfolio Manager, Select Biotechnology Portfolio and Advisor Biotechnology Fund, Fidelity Investments

Mehmood Khan, Executive Vice President and Chief Scientific Officer, PepsiCo

Judith Monroe, Director, Office of State, Tribal, Local and Territorial Support, CDC

12


3:55 PM – 4:10 PMP

LE

NA

RY CLOSING REMARKS

TOM FRIEDEN AND MIKE MILKENAuditorium A

4:15 PM – 5:00 PM

CLOSING RECEPTION HOSTED BY TOM FRIEDEN AND MIKE MILKEN

OPTIONAL TOUR OF THE EMERGENCY OPERATIONS CENTER

Atrium

13

PANELISTS

MARGARET ANDERSON is the executive director of FasterCures, a Milken Institute center that works to speed up the timeline for medicines to go from discovery to patients. A founding board member of the Alliance for a Stronger FDA, Anderson is a member of the NIH National Center for Advancing Translational Sciences Advisory Council and Cures Acceleration Network Review Board, the National Health Council board, the United for Medical Research Steering Committee, and the Institute of Medicine’s Forum on Drug Discovery, Development and Translation. Previously, she was the deputy director of the Center on AIDS & Community Health at the Academy for Educational Development; program director at the Society for Women’s Health Research; health science analyst at the American Public Health Association; and project director at the Congressional Office of Technology Assessment in the Biological Applications Program. She holds a B.S. from the University of Maryland and an M.S. in science, technology, and public policy from George Washington University.

ANNA BARKER is Arizona State University’s director of Transformative Healthcare Networks, co-director of the Complex Adaptive Systems Initiative, and professor in the School of Life Sciences. Prior to this position, Barker served as deputy director at the National Cancer Institute (NCI). While at NCI, Barker developed multi- and trans-disciplinary programs, including the Nanotechnology Alliance for Cancer, The Cancer Genome Atlas, Clinical Proteomics Technologies Initiative for Cancer, and a network of Physical Sciences-Oncology Centers. She also developed the Cancer Human Biobank and Cancer Bioinformatics Grid. Before NCI, Barker served at Battelle Memorial Institute for 18 years. Barker has received many awards, including being named in 2009 as one of "The 100 People Changing America" by Rolling Stone magazine. Barker completed her doctorate at The Ohio State University.

14


BETH BELL is director of the National Center for Emerging and Zoonotic Infectious Diseases at the Centers for Disease Control and Prevention. The center works to improve public health in the U.S. and around the world by protecting people from foodborne and waterborne illnesses; deadly diseases like Ebola, anthrax, and rabies; infections spread to people by animals, mosquitoes, and ticks; health care-associated infections; drug-resistant threats; and diseases that cross borders. Bell has held various leadership posts at CDC and has played key roles in major crises including the 2001 anthrax attacks, Hurricane Katrina, the H1N1 influenza pandemic and the 2012 outbreak of fungal meningitis. She is a fellow of the Infectious Diseases Society of America, the American Academy of Family Medicine, and the American Academy of Preventive Medicine, and she is a member of the American Epidemiological Society. She holds a B.A. from Brown University, an M.D. from Yale University, and an M.P.H. from the University of Rochester School of Medicine.

MICHAEL BELL is deputy director of the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention. The division promotes the protection of patients and health-care personnel and improvements in the safety and quality of health care. It produces guidelines for preventing health care-associated infections, programs for preventing antimicrobial resistance, and improvements in basic medical practices such as safe injections. Bell’s first position at the CDC was in the Hospital Infections Program investigating outbreaks of health care-associated illnesses and writing national infection control guidelines. Prior to his current position, he was the chief of the Epidemiology Unit at the Viral Special Pathogens Branch, addressing infection control for high-risk pathogens such as the Ebola virus. Bell received his M.D. from the University of Washington; he trained in internal medicine at the University of Colorado and in infectious diseases at the University of California, San Francisco.

PANELISTS

15

SANFORD D. BISHOP JR. is serving his 11th term representing Georgia in the U.S. House of Representatives. As a member of the House Appropriations Committee, Bishop has worked to create and maintain jobs, rebuild infrastructure, strengthen schools, bridge the digital divide, fund innovative agriculture research, promote national security, and develop communities—all within the context of a balanced budget. A fiscal conservative, Bishop supports small-business lending, eliminating the estate tax, cutting wasteful spending, and closing tax loopholes that send U.S. jobs overseas. Bishop has held a number of leadership positions including senior Democratic whip and ranking member of the Appropriations Subcommittee on Military Construction and Veterans Affairs. He was first elected to Congress in 1992 after serving in the Georgia House of Representatives (1977-1990) and the Georgia Senate (1991-1992). He graduated from Morehouse College and Emory University Law School.

LARRY BRILLIANT is president and CEO of the Skoll Global Threats Fund, which works to reduce the threat of pandemics, nuclear proliferation, climate change, Middle East conflict and water scarcity. A physician and epidemiologist, Brilliant played a key role in the World Health Organization’s smallpox-eradication program. He was founding chairman of the Centers for Disease Control and Prevention’s National Biosurveillance Advisory Subcommittee, was the first executive director of Google.org and is co-founder of the Seva Foundation, whose work has helped restore sight to 3.5 million people. In 2008, Time magazine named Brilliant one of the world’s 100 most influential people. He received a 2006 TED Prize and was named a Public Health Hero by the University of California, Berkeley, and a Public Health Champion by the University of California, Los Angeles. Brilliant, a former professor of international health and epidemiology, holds an M.P.H. from the University of Michigan and an M.D. from the Wayne State University School of Medicine.

16


STEVEN BURD is CEO of Burd and Co. and former chairman and CEO of Safeway Inc. During his tenure, the company outperformed the S&P 500 on total shareholder return by 34 percent. This achievement is particularly noteworthy given the narrow margins of the supermarket sector. While at Safeway, Burd participated actively in the policy discussions that led to the Affordable Care Act, arguing for a more market-based solution to the nation’s health-care challenges. The discussions led to the so-called Safeway amendment, which permits self-insured employers to differentiate employee health-care premiums (based on behavior) by as much as 30 percent of total cost and potentially 50 percent. Burd is now engaged full time in the health-care sector. He recently formed Burd Health, a company that helps large self-insured employers reduce their health-care costs. Burd believes that his company can reduce almost any large employer’s health-care spending 20 percent to 40 percent per year without adding to the employee cost burden.

ROBERT P. CASEY JR. is the senior Democratic senator from Pennsylvania, elected in 2006 and reelected in 2012. He fights every day for Pennsylvania jobs and families, advocating for the education and well-being of children and pursuing a national security strategy that protects U.S. interests and supports its troops. He serves as chair of the House Finance Committee’s Subcommittee on Fiscal Responsibility and Economic Growth; chair of the Subcommittee on Employment and Workplace Safety on the Health, Education, Labor and Pensions Committee; and a member of the Joint Economic Committee, the Agriculture Committee, the Special Committee on Aging and the National Security Working Group. Casey previously served eight years as Pennsylvania auditor general and two years as state treasurer. He is a graduate of the College of the Holy Cross and received his law degree from Catholic University.

PANELISTS

17

GARY COHEN is an executive vice president at BD (Becton, Dickinson and Company), a global medical technology company with 30,000 associates in more than 50 countries. He also serves as acting CEO of GBCHealth, board chair of the CDC Foundation, vice chair of the U.N. Special Envoy’s Office for MDG Financing and a board director of the Perrigo Company, the U.S. Fund for UNICEF and Accordia Global Health Foundation. Cohen and BD are engaged in the public, private and NGO sectors to address unmet global health needs. He serves as an advocate and expert speaker on global health, child immunization, HIV/AIDS and strengthening health systems. Cohen founded Together for Girls, a partnership to end violence against children. He has been honored by Medical Education for South African Blacks, B’nai B’rith International, the U.S. Fund for UNICEF, the Nyumbani Children’s Home for orphaned HIV-positive children and the Dikembe Mutombo Foundation. He holds a B.A. and an M.B.A. from Rutgers University.

NATHAN DEAL took the oath of office as Georgia’s 82nd governor in January 2011. The Republican governor’s top goal is to make Georgia the No. 1 place in the nation to do business, a goal he’s worked toward by creating the Competitiveness Initiative, reforming the tax code and recruiting businesses to relocate. Deal’s public service spans four decades, including as a prosecutor, a judge, a state senator and a U.S. congressman. A 17-year veteran of Congress, he rose to chair of the Health Subcommittee of the Energy and Commerce Committee, where he became a noted expert on entitlement reform and health-care policy. Before that, Deal practiced law in Gainesville, Ga. He served in the U.S. Army at Fort Gordon in Augusta after graduating with a law degree from Mercer University.

18


ROSS DEVOL is chief research officer at the Milken Institute. He oversees research on international, national and comparative regional growth performance; technology and its impact on regional and national economies; access to capital and its role in economic growth and job creation; and health-related topics. He was the principal author of "The Global Biomedical Industry: Preserving U.S. Leadership," a study that showed that the United States is still the global leader in the biomedical industry, but that countries across Europe and Asia are pursuing aggressive plans to take high-value jobs. He was also the principal author of "An Unhealthy America: The Economic Burden of Chronic Disease," which brought to light the economic losses associated with preventable illnesses and estimated the avoidable costs if a serious effort were made to improve Americans’ health. DeVol is ranked among the "Super Stars" of Think Tank Scholars by International Economy magazine.

ROBYN NEBLETT FANFAIR is an epidemiologist in the Division of STD Prevention at the Centers for Disease Control and Prevention. She completed her applied epidemiology training as an Epidemic Intelligence Service officer in the CDC’s Mycotic Diseases Branch, where she led outbreak investigations into rare fungal infections among populations including tornado survivors and intensive-care unit patients. A board-certified internist, she holds an M.D. from New York University, a master’s of public health from the Johns Hopkins Bloomberg School of Public Health, and a B.A. from Brown University.

PANELISTS

19

VINCE FORLENZA is chairman, CEO and president of BD (Becton, Dickinson and Company), a global medical technology company headquartered in Franklin Lakes, N.J. Forlenza is active in various professional and community associations. He serves on the board of the Advanced Medical Technologies Association (AdvaMed) and spent more than three years as the chairman of AdvaMedDx, a division of AdvaMed that focuses solely on in-vitro diagnostic technologies. In addition, Forlenza serves on the board of trustees at The Valley Hospital and at Lehigh University. He is also a member of the advisory board for Lehigh’s P.C. Rossin College of Engineering and Applied Sciences. Forlenza holds an M.B.A. from the Wharton School of the University of Pennsylvania and a bachelor’s degree in chemical engineering from Lehigh University.

THOMAS FRIEDEN is the director of the U.S. Centers for Disease Control and Prevention, our nation’s health protection agency. Since joining the CDC in 2009, he has worked to control threats from infectious diseases, respond to emergencies, and battle the leading causes of death in our nation and around the world. Under his direction, new CDC programs have prevented infections from food and health care, helped Americans quit smoking, reduced childhood obesity, saved the lives of teens and others from car crashes, and extended life-saving treatment and disease prevention in more than 50 countries. He previously led New York City’s program that cut multidrug-resistant tuberculosis by 90 percent, and helped India prevent more than 3 million tuberculosis deaths. As New York City’s health commissioner from 2002 to 2009, he helped reduce teen smoking by half and adult smoking by one-third. Frieden received his medical and master’s of public health degrees from Columbia University. He completed infectious disease training at Yale University.

20


LYNN GOLDMAN is dean of the School of Public Health and Health Services at George Washington University. Before joining SPHHS in 2010, she was a professor of environmental health sciences at Johns Hopkins University’s Bloomberg School of Public Health. Prior to that, Goldman served as assistant administrator for the Environmental Protection Agency’s Office of Chemical Safety and Pollution Prevention. Goldman is on the board of the Environmental Defense Fund; she is a member of the Institute of Medicine, where she serves on the governing council, and the National Academy of Sciences Board on Environmental Sciences and Toxicology. In 2013, Goldman received an honorary doctorate from Orebro University in Sweden for her contributions to chemical legislation in the U.S. and Sweden. She holds a B.S. in conservation of natural resources and an M.S. in health and medical science from the University of California, Berkeley; an M.P.H. from Johns Hopkins University; and an M.D. from the University of California, San Francisco.

DAVID HEBER is a professor emeritus of medicine and public health at the University of California, Los Angeles, founding chief of UCLA’s Division of Clinical Nutrition and founding director of the UCLA Center for Human Nutrition. He is board-certified in internal medicine, endocrinology and metabolism, and clinical nutrition. Heber is past chairman of the Education Committee and the Medical Nutrition Council of the American Society for Nutrition. He has written more than 200 peer-reviewed scientific articles and over 60 book chapters as well as two professional texts and four books for the public. His main research interests are obesity treatment and nutrition for cancer prevention and treatment. Heber holds a bachelor’s degree in chemistry and a Ph.D. in physiology from UCLA and an M.D. from Harvard Medical School.

PANELISTS

21

ROBERT HUGIN has been CEO at Celgene since 2010 and chairman since 2011. Since joining the company in 1999, he has held numerous leadership positions, including president, chief operating officer, director, senior vice president and chief financial officer. Hugin is also chairman of the Pharmaceutical Research and Manufacturers of America. Previously, he was a managing director at J.P. Morgan & Co. Inc., which he joined in 1985. Hugin serves on the boards of The Medicines Company, Atlantic Health System Inc., and Family Promise, and is past chairman of the HealthCare Institute of New Jersey. He received a B.A. from Princeton University and an M.B.A. from the University of Virginia and served as an infantry officer in the U.S. Marine Corps.

JOHNNY ISAKSON is a U.S. senator from Georgia. Also a businessman and family man, his conservative, thoughtful and independent approach has made him a leader in the state for more than 30 years. In January 2013, Isakson, a Republican, was named to the Senate Committee on Finance, which has jurisdiction over taxes, trade, Medicare and Social Security and plays a critical role in the debate over spending and our nation’s debt. He was re-elected to the upper chamber in 2010. In politics, he has served in the Georgia House, the Georgia Senate, and as chairman of the Georgia Board of Education, and was elected to the U.S. House three times before winning his U.S. Senate seat in 2004. In the private sector, Isakson served as president of Northside Realty for 20 years, leading the company as it grew into the largest independent residential real estate brokerage in the Southeast.

22


CHERYL JAEGER is the senior health policy advisor to the majority leader of the U.S. House of Representatives, Eric Cantor. In this role, she leads the advancement of health-care reform legislation to improve patient choice, lower health-care costs and expand innovation. Jaeger previously served as a senior advisor to former Majority Whip Roy Blunt. Prior to working as a leadership aide, Jaeger was a professional staff member for the House Committee on Energy and Commerce. She was the lead staff negotiator for the National Institutes of Health Reform Act of 2006 in addition to several other pieces of legislation. Jaeger began her tenure on Capitol Hill more than 14 years ago as a legislative aide to former Congressman Christopher Cox. Jaeger holds a master’s degree in public policy from Georgetown University and is a graduate of the University of Virginia.

LARRY JAMESON is the executive vice president of the University of Pennsylvania for the Health System and dean of the Raymond and Ruth Perelman School of Medicine. Before joining Penn Medicine, he was dean of the Feinberg School of Medicine and vice president of medical affairs at Northwestern University. Jameson has been a pioneer in molecular medicine in the field of endocrinology. His research has focused on the genetic basis of hormonal disorders. He is the author of more than 300 scientific articles and chapters, and his work has been published in leading peer-reviewed and endocrinology journals. He is an editor of Harrison’s Principles of Internal Medicine, the most widely used medical text worldwide, and co-editor with Leslie J. De Groot of Endocrinology. His many honors include election to the American Academy of Arts and Sciences as well as the Institute of Medicine. Jameson received his medical degree and a doctoral degree in biochemistry from the University of North Carolina.

PANELISTS

23

RAJIV KAUL is a portfolio manager responsible for the Select Biotechnology Portfolio and Advisor Biotechnology Fund for Fidelity Investments. In his 17 years at Fidelity, Kaul has been widely recognized for his leadership within the biotech industry and has often been ranked among the top U.S. health-care investors. In 2013, Kaul received the Lipper Award for the best three-year risk-adjusted performance in his sector. He is a member of the Research Advisory Council at Massachusetts General Hospital, the teaching hospital for Harvard Medical School. Kaul worked at McKinsey & Co. before joining Fidelity. He is a graduate of Harvard University.

ALI KHAN is director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention and a retired U.S. assistant surgeon general. Responsible for the CDC’s public health preparedness and response activities, Khan has served as one of the main architects of the CDC’s bioterrorism preparedness program. Over his 21 years with the CDC, Khan has responded to numerous high-profile domestic and international public health emergencies, written over 150 publications, and consulted for agencies including NASA and the World Health Organization.

24


MEHMOOD KHAN is executive vice president and chief scientific officer, global research and development, for PepsiCo. As chief scientific officer, Khan leads companywide research and development; recruits highly regarded clinical scientists, global health leaders and medical experts; launches research projects with leading universities; and oversees advanced R&D facilities. As executive vice president, Khan leads a global team of experts in nutrition, medicine, research, science, ingredient sourcing and product innovation. He directs PepsiCo’s enterprise planning, portfolio development and execution of new technology to expand the company’s nutrition-focused brands in four areas: grains (Quaker), fruits (Tropicana), vegetables (Sabra) and dairy (Wimm-Bill-Dann). With the creation of the Global Nutrition Group, PepsiCo is one of just two food and beverage companies worldwide with an operation dedicated to health and wellness.

JACK KINGSTON is the U.S. representative from Georgia’s 1st District, which incorporates 17 counties in southeast Georgia, including the state’s entire coastline. Kingston was appointed to the House Appropriations Committee in his second term and today serves as chairman of the Labor, Health and Human Services, Education and Related Agencies Subcommittee, which oversees federal spending on worker safety, health, education, and retirement security programs. He also is a senior member of the Defense Appropriations Subcommittee. From 2008 to 2012, Kingston was the top Republican on the House Agriculture Appropriations Subcommittee. Before his election to Congress, Kingston sold agribusiness insurance as a vice president at a regional insurance brokerage. He also served in the Georgia State House from 1985 to 1992. Kingston is a graduate of the University of Georgia, where he earned a degree in economics.

PANELISTS

25

MICHAEL KLOWDEN is CEO of the Milken Institute. During his tenure, the Institute’s annual Global Conference has become one of the world’s premier business, finance and policy events. Under his leadership, the Institute dramatically enhanced its worldwide outreach; significantly increased its convening capacity; initiated specialized research centers, including the Asia Center, the California Center and the Israel Center; established a major presence in Washington, D.C., with the founding of FasterCures and the Center for Financial Markets; and expanded the use of Financial Innovations Labs that suggest solutions to specific challenges. Previously Klowden was president of Jefferies Group Inc.; senior partner at Morgan, Lewis & Bockius; and partner at Mitchell, Silberberg & Knupp. He has served on numerous for-profit and charitable boards. Klowden holds a bachelor’s degree from the University of Chicago, where he is now a trustee, and a J.D. from Harvard Law School.

JOHN LANGE is senior fellow for global health diplomacy at the United Nations Foundation. Before joining the foundation in July 2013, Lange worked on global health issues at the Bill & Melinda Gates Foundation. He has served as co-chair of the Global Polio Eradication Initiative’s Polio Partners Group since its launch in 2012. During his career in the Foreign Service at the U.S. State Department, Lange served as special representative on avian and pandemic influenza, deputy U.S. global AIDS coordinator, and ambassador to Botswana. He led the U.S. Embassy in Dar es Salaam, Tanzania, during the August 7, 1998, terrorist bombing, for which he received the State Department’s Distinguished Honor Award. Lange managed refugee assistance at the U.S. mission to the U.N. in Geneva and earlier had tours of duty at U.S. embassies in Togo, France and Mexico. He has degrees from the National War College, the University of Wisconsin Law School and the University of Wisconsin, Madison.

26


FREDA LEWIS-HALL is executive vice president and chief medical officer of Pfizer, Inc. Trained as a psychiatrist, Lewis-Hall has held leadership roles in academia, medical research, frontline patient care and global biopharmaceutical companies. Prior to her work in industry, she led research projects for the National Institutes of Health and was vice chair of the department of psychiatry at Howard University College of Medicine. In 2012, Lewis-Hall was appointed chair of the Cures Acceleration Network Review Board and a member of the National Center for Advancing Translational Sciences Advisory Council of the National Institutes of Health. In 2010, she was appointed to the inaugural board of governors for the Patient-Centered Outcomes Research Institute. She also serves on the Executive Committee of the Clinical Trials Transformation Initiative and other boards, including Harvard Medical School; the Institute of Medicine’s Forum on Drug Discovery, Development and Translation; and Save the Children.

JAMES MARKS is a senior vice president of the Robert Wood Johnson Foundation Health Group. He directs the group’s program and administrative activities, including RWJF’s work in childhood obesity, public health and vulnerable populations. Prior to joining RWJF, Marks retired as assistant surgeon general after almost a decade as the director of the Centers for Disease Control’s National Center for Chronic Disease Prevention and Health Promotion. At the CDC, Marks developed and advanced systematic ways to prevent and detect diseases such as cancer, heart disease and diabetes, as well as strategies to reduce tobacco use and address the growing epidemic of obesity. A public health advocate for more than 35 years, Marks has published extensively in the areas of maternal and child health, health promotion and chronic disease prevention, and has served on many related government and nonprofit committees. Marks received an M.D. from the State University of New York at Buffalo and an M.P.H. from Yale University, where he was a Robert Wood Johnson Clinical Scholar.

PANELISTS

27

ANDREA MCCOLLUM is an epidemiologist on the poxvirus team at the Centers for Disease Control and Prevention. She has led outbreak investigations in the Democratic Republic of the Congo (DRC) and several investigations regarding exposures to poxviruses in the U.S. McCollum currently works to enhance surveillance for monkeypox , improve health-care worker capacity, and improve laboratory diagnostics in the DRC. McCollum became an EIS officer in 2009 after completing an American Society for Microbiology postdoctoral fellowship at the CDC. She holds an M.S. in genetics from the University of Georgia and a Ph.D. from Emory University in population biology, ecology and evolution.

JENNIFER MCQUISTON is an epidemiologist in the Centers for Disease Control and Prevention’s Rickettsial Zoonoses Branch in the National Center for Emerging and Zoonotic Infectious Diseases. As an epidemiology team leader, she heads outbreak investigations and surveillance programs for diseases like Rocky Mountain spotted fever, ehrlichiosis, and Q fever. A veterinarian by training, McQuiston is a graduate of the CDC’s Epidemic Intelligence Service. Since joining the CDC in 1998, she has spent her career investigating and preventing diseases transmitted between animals and people. A captain in the U.S. Public Health Service, she is a past recipient of the Daniel E. Salmon award for federal veterinarians and the CDC’s James H. Steele Veterinary Public Health Award. McQuiston holds a doctorate of veterinary medicine and an M.S. in molecular biology from Virginia Tech.

28


MICHAEL MILKEN has been at the forefront of initiatives in public policy, medical research, public health and access to capital for four decades. A Fortune cover story called him "The Man Who Changed Medicine." Milken formalized his previous philanthropy in 1982 by co-founding the Milken Family Foundation. In 1998 he led a March on Washington for increased funding of biomedical research and later founded FasterCures, which removes barriers to progress against all life-threatening diseases. He also founded the Prostate Cancer Foundation and helped launch the Melanoma Research Alliance. In 2012, he led the Celebration of Science to reaffirm the importance of bioscience. He chairs the Milken Institute, whose annual Global Conference brings 3,500 decision makers from 50 nations to Los Angeles. As a financier, he revolutionized capital markets by expanding access to capital for 3,200 companies that created millions of jobs. Milken graduated from UC Berkeley with highest distinction and earned his M.B.A. from the Wharton School. See www.mikemilken.com.

JUDITH MONROE is a deputy director of the Centers for Disease Control and Prevention and the director of the CDC’s Office for State, Tribal, Local and Territorial Support. Her work focuses on establishing a systems approach that supports integration and collaboration among public health professionals and on translating science into practice to increase the capacity and performance of public health agencies. Monroe served as the Indiana state health commissioner from 2005 to 2010, concentrating on health promotion and prevention, preparedness, medical error prevention, and quality improvement. She has also served as president of the Association of State and Territorial Health Officials and was vice president of the Public Health Accreditation Board. Monroe holds an undergraduate degree from Eastern Kentucky University and an M.D. from the University of Maryland. She completed her residency in family medicine at the University of Cincinnati.

PANELISTS

29

TREVOR MUNDEL is president of the Bill & Melinda Gates Foundation’s Global Health Program. The program harnesses innovations in science and technology to fight diseases such as HIV/AIDS, tuberculosis and malaria – problems that have a major impact in developing countries but receive inadequate attention and funding. Mundel oversees the program’s work, leading research and development efforts toward solutions that include vaccines, drugs and diagnostics. Mundel joined the foundation in 2011. He earned his bachelor’s and medical degrees at the University of the Witwatersrand in South Africa and his Ph.D. in mathematics at the University of Chicago. A Rhodes Scholar, he also studied mathematics, logic and philosophy at Balliol College at the University of Oxford.

VICTORIA NAHUM is executive director of the Safe Care Campaign, whose mission is to prevent health-care- and community-acquired infections. In 2006, three members of Nahum’s family became infected with health-care-associated infections in three hospitals in three different states. Her stepson, Josh, died from his infection, but only after it rendered him a permanent ventilator-dependent quadriplegic. He was 27. Since starting the Safe Care Campaign, Nahum and her husband and co-founder, Armando, work with the American health-care system through speaking engagements, educational programs, and the creation of tools, educational videos and guides. The family’s story has been showcased on CNN’s The Situation Room, on the CBS Evening News, on the Dr. Oz Show and in the New York Times. Nahum sits on the Joint Commission’s Patient and Family Advisory Council. She recently addressed lawmakers on Capitol Hill and is working with the Centers for Medicare & Medicaid Services to support their ongoing work to deliver safer health care.

30


KENT NELSON was chairman and CEO of United Parcel Service from 1989 to 1996. He served on the UPS board until 2002, when he stepped down after 43 years of service with the company. Nelson currently serves as chairman of the board of trustees of the Carter Center. Previously, he served on the boards and executive committees of United Way of America, the Ball State University Foundation, the Jim Casey Youth Opportunity Initiative and the National Museum of Patriotism. He has chaired the boards of the CDC Foundation, the Annie E. Casey Foundation, United Way of Metropolitan Atlanta and the UPS Foundation. He also served as a member of the National Business Roundtable Policy and Education Committee and was appointed to the Georgia Governor’s Education Reform Commission. Nelson has served as a guest lecturer at the Massachusetts Institute of Technology, the University of Pennsylvania, Auburn University, Hillsdale College, the University of Maryland, Kennesaw State University and Ball State University.

LANCE PRICE is a professor in the Department of Environmental and Occupational Health at George Washington University’s School of Public Health and Health Services. A public health researcher, Price works at the interface between science and policy to address the growing crisis of antibiotic resistance. In the laboratory, he uses whole genome sequence-based analyses to trace the origins of new antibiotic-resistant pathogens. By analyzing the genomes of bacteria found in humans, food and livestock, Price and his colleagues are trying to quantify how often antibiotic-resistant bacteria make their way from food animals to people. In the policy arena, Price works with grass-roots organizations, NGOs and decision-makers to develop science-based policies to curb the misuse of antibiotics and stem the emergence of new superbugs. Price’s research has also been covered by media around the world, including the BBC, New York Times, Los Angeles Times, Chicago Tribune, Scientific American, Men’s Journal and Fitness Magazine.

PANELISTS

31

CARMEN PULIAFITO is dean of the Keck School of Medicine of the University of Southern California, a position he has held since 2007. He continues to lead the transformation of the Keck School into one of the nation’s preeminent research-intensive medical schools. Puliafito is a renowned ophthalmologist, recognized for his innovative advances in treatment, including his co-invention of optical coherence tomography, which revolutionized laser surgery. He is also an active clinician at USC’s Doheny Eye Institute and serves as the editor of Ophthalmic Surgery, Lasers and Imaging. From 2001 to 2007, Puliafito served as chair of the Department of Ophthalmology at the Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine. Previously he served as founding director of the New England Eye Center and chair of the Department of Ophthalmology at Tufts University (1991-2001). A graduate of Harvard College and Harvard Medical School, Puliafito also earned an M.B.A. from the Wharton School of the University of Pennsylvania.

DAVID RATCLIFFE is the retired chairman, president and CEO of Southern Company, one of America’s largest producers of electricity. An employee of Southern Company and its subsidiaries since 1971, Ratcliffe become president, CEO and chairman in 2004. He serves on the boards of the CDC Foundation, CSX Transportation, Children’s Healthcare of Atlanta, SunTrust and Urjanet. He is also a member of the Georgia Bar Association.

32


JUDITH RODIN is the president of The Rockefeller Foundation, one of the world’s leading philanthropic organizations. Prior to the Rockefeller Foundation, she was the president of the University of Pennsylvania and provost of Yale University. Rodin was the first woman to lead an Ivy League institution and the first woman to serve as the Rockefeller Foundation’s president in its 100-year history. Since joining the foundation in 2005, Rodin has recalibrated its focus. Today the foundation supports and shapes innovations to strengthen resilience to risks and ensure that more people have access to the benefits of globalization. Rodin is the author of more than 200 academic articles and the author or co-author of 12 books. She serves on the boards of AMR Corp., Citigroup, Comcast and the White House Council for Community Solutions, among others. Rodin also served as co-chair of New York Gov. Andrew Cuomo’s NYS 2100 Commission. Rodin is a graduate of the University of Pennsylvania and earned her Ph.D. in psychology from Columbia University.

DAVID SCHLANGER became CEO of WebMD in August 2013. Schlanger has held several senior roles at WebMD and its predecessor companies since signing on in 1995. Most recently, he was senior vice president of strategic and corporate development, responsible for the strategy, sourcing, diligence and negotiation of the numerous acquisitions that provide the foundation of WebMD’s business. Schlanger and his team were also responsible for sales, marketing and product development support throughout the organization in addition to WebMD’s relationships with strategic media, technology and content partners. Earlier in his career, he was executive director of business development at Merck & Co. Schlanger holds a J.D. from the University of Michigan School of Law and a B.A. in economics from Georgetown University.

PANELISTS

33

ANNE SCHUCHAT is the director of the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention. The center, which she has led since 2006, administers the Vaccines for Children Program and facilitates global disease prevention through accelerated uptake of vaccines and strengthened disease surveillance and response. Schuchat was the CDC’s chief health officer during the 2009 H1N1 influenza pandemic; she also assisted with responses to SARS in China and with studies of pneumonia and meningitis vaccines in Africa. During the 1990s, she spearheaded national prevention guidelines that reduced newborn group B streptococcal infections by 80 percent. Schuchat has held multiple positions at the CDC, serving as interim deputy director and as acting director of the Center for Global Health. A member of the Institute of Medicine, Schuchat is also an assistant surgeon general and rear admiral in the U.S. Public Health Service Commissioned Corps.

SUE SIEGEL works on GE’s growth and innovation initiatives as CEO of two company-wide platforms: GE Ventures, which partners entrepreneurs with GE capabilities and investments; and healthymagination, which harnesses innovation and partnership to drive better health outcomes. Sue is a 25-year industry leader with corporate and venture capital experience in growing technology companies in biomedical research and healthcare. Prior to joining GE, she was a General Partner at Mohr Davidow Ventures. Sue has been featured in the bestselling business book: Multipliers: How The Best Leaders Make Everyone Smarter and was recognized as one of “The 100 Most Influential Women in Silicon Valley.”

34


RACHEL SMITH is an epidemiologist with the Mycotic Diseases Branch of the Centers for Disease Control and Prevention. She joined the CDC in 2011 after completing her residency in internal medicine at the University of California, San Francisco, where she earned her medical degree. Smith also holds a master’s in public health from the University of California, Berkeley.

CHARLES STOKES is president and CEO of the CDC Foundation, a nonprofit that supports the work of the U.S. Centers for Disease Control and Prevention. Stokes joined the organization as its first leader in 1995. Before that, he worked for 22 years with the Missouri Department of Health, serving as deputy director from 1983 through 1994. Stokes has served as president of the Missouri Public Health Association and the Missouri Institute of Public Administration. Currently, he is vice chairman of the Atlanta-based Raoul Foundation Board and a member of the Advisory Committee on Public Issues for the Ad Council. In 1989, Stokes received the Noble J. Swearingen Award from the Association of State and Territorial Health Officials for excellence in administrative management. He also received a Public Health Leadership Award from St. Louis University in 1995 and the Atlanta Business Chronicle’s Health-Care Heroes Lifetime Achievement Award in 2013.

PANELISTS

35

KENNETH THORPE is the Robert W. Woodruff professor and chair of the Department of Health Policy and Management in the Rollins School of Public Health of Emory University in Atlanta. Thorpe is also a member of the international advisory board for APCO Worldwide. In addition, he serves as the chairman of the Partnership to Fight Chronic Disease. In this capacity, Thorpe works with an international coalition organization consisting of patients, providers, community organizations, business and labor groups, and health policy experts to raise awareness of the negative impact of chronic disease on health and the economy. He is also co-chairman of the Partnership for the Future of Medicare, a bipartisan group designed to ensure the sustainability of the program. Thorpe received a Ph.D. from the Pardee RAND Graduate School, an M.A. from Duke University, and a B.A. from the University of Michigan.

ANDREW VON ESCHENBACH is president of Samaritan Health Initiatives, Inc., and an adjunct professor at the University of Texas MD Anderson Cancer Center in Houston. He was commissioner of the U.S. Food and Drug Administration from 2005 to 2009 after serving four years as director of the National Cancer Institute at the National Institutes of Health. His career spans more than three decades as a physician, surgeon, oncologist and executive, including serving as chairman of the Department of Urologic Oncology, executive vice president and chief academic at the MD Anderson Cancer Center. He is the author of more than 300 scientific articles and currently serves on the boards of Elan Corp., BioTime Inc., Viamet Pharmaceuticals, Banyan Diagnostics and Histosonics. A member of the GE healthymagination Advisory Board, he is a board member of the Prostate Cancer Foundation and a senior fellow at the Milken Institute. Von Eschenbach earned a B.S. from St. Joseph’s University and an M.D. from Georgetown University School of Medicine.

36

PARTICIPANTS (as of January 29)

Terry Allan President National Association of County and City Health Officials (NACCHO)

Clay Alspach Chief Counsel, Health U.S. House Committee on Energy and Commerce

Abigail Alvarez Alvarez & Marsal

Antonio Alvarez Co-CEO Alvarez & Marsal

Margaret Anderson Executive Director FasterCures

Laura Angel Associate Vice President for Advancement CDC Foundation

Rhona Applebaum Vice President, Chief Science and Health Officer The Coca-Cola Company

Ileana Arias Principal Deputy Director CDC

Cecilia Arradaza Managing Director, Communications and Policy FasterCures

Peter Attia President Nutrition Science Initiative

Brett Baker CEO Microbion

Gillian Barclay Vice President Aetna Foundation

Wanda Barfield Director, Division of Reproductive Health CDC

Anna Barker Director, Transformative Healthcare Networks, and Co-Director Complex Adaptive Systems Initiative Arizona State University

Bob Barth CEO Black Equities Group

Jeffrey Batoff Senior Partner Obermayer Rebmall Maxwell and Hippel

Michael Bator Director Jennison Associates

Beth Bell Director, National Center for Emerging and Zoonotic Infectious Diseases CDC

Michael Bell Deputy Director, Division of Healthcare Quality Promotion CDC

Sherri Berger Chief Operating Officer CDC

Sanford Bishop U.S. Representative Georgia

Greg Bontrager President and COO American Cancer Society

Larry Brilliant President and CEO Skoll Global Threats Fund

Becky Bunnell Associate Director for Science, Office on Smoking and Health CDC

37

PARTICIPANTS

Steven Burd CEO Burd and Company Former Chairman and CEO Safeway Inc.

Ron Burkle Managing Partner Yucaipa Companies

Denise Cardo Director, Division of Healthcare Quality Promotion CDC

Robert P. Casey Jr. U.S. Senator Pennsylvania

Michael Cassidy President and CEO Georgia Research Alliance

Brian Castrucci Chief Program and Strategy Officer de Beaumont Foundation

Anusuya Chatterjee Senior Economist Milken Institute

Tom Chiller Deputy Branch Chief, Mycotic Diseas-es, Division of Foodborne, Waterborne and Environmental Diseases CDC

Gary Cohen Executive Vice President BD (Beckton, Dickinson and Company)

Janet Collins Director, Division of Nutrition, Physical Activity and Obesity CDC

Chris Cook Managing Director Guggenheim Partners

Allan Coukell Senior Director, Drugs & Medical Devices The Pew Charitable Trust

Kenneth Cutts District Director Office of Congressman Sanford Bishop

Katherine Lyon Daniel Associate Director for Communication CDC

Scott Davis Chairman and CEO United Parcel Service

Robert Deuson Senior Managing Economist, Health Economics Milken Institute

Ross DeVol Chief Research Officer Milken Institute

William Dietz Consultant Institute of Medicine Senior Advisor Robert Wood Johnson Foundation

Richard Ditizio Executive Director, Business and Program Development Milken Institute

Carlos Dominguez Senior Vice President Cisco Systems

Scott Dowell Senior Advisor, Global Health Security CDC

John Drew General Partner Technology Crossover Ventures

Dianna Dunne Director, Government Affairs Milken Institute

Jennifer Ellis Director of Evaluation, Public Health Bloomberg Philanthropies

Robyn Neblett Fanfair Medical Epidemiologist CDC

Andrew Farquharson Managing Director VentureHealth

William Finneran Managing Member EXOP Capital LLC

Vincent Forlenza Chairman, President and CEO BD (Beckton, Dickinson and Company)

38


Thomas Frieden Director U.S. Centers for Disease Control and Prevention

Kate Galatas Deputy Associate Director for Communication CDC

Elisa Gambino Partner One Production Place

Mike Gerber Chief, Global Disease Detection Branch CDC

Alan Gilbert Director, Global Government and NGO Strategy healthymagination, GE

Lynn Goldman Dean, School of Public Health and Health Services George Washington University

Sam Gonzalez Director of Operations, Pfizer Medical Pfizer Inc.

Eric Goosby Professor of Clinical Medicine University of California, San Francisco

Corrine Graffunder Acting Associate Director for Policy CDC

Althea Grant Chief, Epidemiology and Surveillance, Division of Blood Disorders CDC

Jeff Greene Investor and Philanthropist

Edward Greissing Senior Vice President, Corporate Affairs Sanofi

Janet Hammond Global Head, Infectious Diseases DTA F. Hoffmann-La Roche Ltd.

Lisha Hancock CDC Guest

Mary Hart Owner m. Hart Inc.

Rebecca Hartz Senior Program Officer CDC Foundation

Georgia F. Heise President-Elect National Association of County and City Health Officials (NACCHO)

David Heber Professor and Director UCLA Center for Human Nutrition

Joe Henderson Director, Office of Safety, Security and Asset Management CDC

Edward Henry President & CEO The Doris Duke Charitable Foundation

Terri Heyns Director of Communications CDC Foundation

Lyda Hill President LH Holdings

Alan Hoffman Senior Vice President, Global Public Policy and Government Affairs PepsiCo

Dee Dee Honaman Vice President for Advancement CDC Foundation

Clark Howard President Clark Howard, Inc.

Robert Hugin CEO and Chairman Celgene Corporation Chairman PhRMA

Ed Hunter Director, Washington Office CDC

Robin Ikeda Deputy Director, Office of Noncommunicable Diseases, Injury and Environmental Health CDC

39

PARTICIPANTS

Paul Irving President Milken Institute

Johnny Isakson U.S. Senator Georgia

Phil Jacobs Partner Pendleton Group

Cheryl Jaeger Senior Health Policy Advisor Majority Leader of the U.S. House of Representatives, Eric Cantor

Harold Jaffe Associate Director for Science CDC

Larry Jameson Senior Vice President University of Pennsylvania for the Health System Dean University of Pennsylvania Medical School

Larry Kaiser President and CEO Temple University Health System Dean Temple University School of Medicine

Ruth Katz Director, Health, Medicine and Society Program Aspen Institute

Neil Kaufman Chief Medical Officer DPS Health

Rajiv Kaul Porfolio Manager Fidelity Investment Management

Phil Kent Chairman Turner Broadcasting System

Tom Kenyon Director, Center for Global Health CDC

Rima Khabbaz Deputy Director, Office of Infectious Diseases CDC

Ali Khan U.S. Assistant Surgeon General (Ret.); Director, Office of Public Health Preparedness & Response CDC

Mehmood Khan Executive Vice President and Chief Scientific Officer PepsiCo

Jack Kingston U.S. Representative Georgia

Michael Klowden CEO Milken Institute

Stephen Knapp President George Washington University

Nicole Kruse Chief Development Officer The Carter Center

David Kyne Founder and CEO KYNE

Pat Lammie Deputy Director, Office of Infectious Diseases CDC

John Lange Senior Fellow, Global Health Diplomacy United Nations Foundation Former U.S. Ambassador to Botswana

Pablo Legorreta Founder and CEO Royalty Pharma

Freda Lewis-Hall Executive Vice President and Chief Medical Officer Pfizer Inc.

Debra Liebert Managing Director Domain Associates LLC

Dennis Lockhart President and CEO Federal Reserve Bank of Atlanta

40


Deb Lubar Senior Advisor, Appropriations, Legislation and Formulation Office CDC

James Marks Senior Vice President Robert Wood Johnson Foundation

Rebecca Martin Director, Global Immunization Division CDC

Gary May Dean of Engineering Georgia Institute of Technology

Andrea McCollum Epidemiologist CDC

Linda McGehee Associate Vice President for Programs CDC Foundation

Jennifer McQuiston Veterinary Medical Officer CDC

Russell Medford CEO Salutramed Group

Jonathan Mermin Director, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention CDC

Mike Milken Chairman Milken Institute

Scott Minerd Managing Partner Guggenheim Partners

Faith Mitchell President and CEO Grantmakers In Health

Steven Mnuchin Chairman OneWest Bank

Kenneth Moch President and CEO Chimerix, Inc.

Michael Moe Co-Founder and Chief Investment Officer GSV Capital

Judith Monroe Director, Office for State, Tribal, Local and Territorial Support CDC

Geoffrey Moore Senior Advisor Milken Institute

Jay Moorin Founding General Partner ProQuest Management LLC

Stephen Morrison Senior Vice President and Director, Global Health Policy Center Center for Strategic & International Studies

Angela Moskow Vice President, Chronic Disease Prevention Sanofi

Lorelei Mucci Associate Professor Harvard School of Public Health

Jewel Mullen President-Elect Association of State and Territorial Health Officials (ASTHO)

Trevor Mundel President, Global Health Program Bill & Melinda Gates Foundation

Erik Murkoff President What to Expect Co-Founder What to Expect Foundation

Heidi Murkoff Creator What to Expect Founder and President What to Expect Foundation

Armando Nahum Co-founder and President Safe Care Campaign

Victoria Nahum Executive Director Safe Care Campaign

Kartik Natarajan Senior Advisor Wood Creek Capital Management

41

PARTICIPANTS

Douglas Nelson President and CEO, Retired Annie E. Casey Foundation

Gary Nelson President Healthcare Georgia Foundation

Kent “Oz” Nelson President and CEO, Retired United Parcel Service

Pierce Nelson Vice President for Communications CDC Foundation

Verla Neslund Vice President for Programs CDC Foundation

David Norris CEO MD Insider

Lydia Ogden Executive Director, Global Vaccine Public Policy Merck Vaccines

Jennifer Olsen Manager, Pandemics Skoll Global Threats Fund

Becky Payne Senior Advisor, Business Engagement and Coordination CDC

Brian Pellegrino Chief Investment Officer United Parcel Service

Pete Petit Chairman and CEO MiMedx Group

Amy Pfaeler DC Finance Director Office of Senator Robert P. Casey Jr.

Alicia Philipp President Community Foundation for Greater Atlanta

Steve Phillips Senior Fellow Chatham House

Jim Pirkle Director, Division of Laboratory Ser-vices CDC

Leslie Platt Principal Leslie Platt & Associates, LLC

Lance Price Professor, Environmental and Occupational Health George Washington University

Anthony Pritzker Managing Partner Pritzker Group

Carmen Puliafito Dean, Keck School of Medicine University of Southern California

David Ratcliffe Chairman, President and CEO, Retired Southern Company

Jim Reddoch Executive Vice President and Head of Research Royalty Pharma

Barbara Reynolds Director, Division of Public Affairs CDC

Brian Reynolds Managing Partner Chatham Capital

Chesley Richards Director, Office of Public Health Scientific Services CDC

Judith Rodin President The Rockefeller Foundation

Neil Rodin President International Finance Company (IFC)

Simone Friedman Rones President Emanuel J. Friedman Philanthropies

Mark Salter Global Health Consultant Public Health England (PHE)

Martin Sanda Chairman, Department of Urology Emory Healthcare

Ellen Sandor

Richard Sandor Chairman and CEO Environmental Financial Products

42


Matthew Sandoval Managing Director Wood Creek Capital Management

Fred Sanfilippo Interim Medical Director Marcus Foundation

Muneer Satter Chairman Satter Investment Management

David Schlanger CEO WebMD

Mark Schmitz Senior Vice President Knowledge Universe–U.S.

Jay Schnitzer HHS Portfolio Director MITRE

Michael Schreiber Executive Director Global Business Coalition for Health

Anne Schuchat U.S. Assistant Surgeon General; Director, National Center for Immunization and Respiratory Diseases CDC

Wendy Selig President and CEO Melanoma Research Alliance

Kevin Sheridan Managing Director, Health Care Investment Banking Jefferies & Company

Donald Shriber Deputy Director, Policy and Communi-cations, Center for Global Health CDC

Sue Siegel CEO healthymagination, GE

Mindy Silverstein Managing Director Milken Institute

Shawn Simmons Director of Communications Programs Knowledge Universe

Mark Simon Advisor Torreya Partners

Jonathan Simons President and CEO Prostate Cancer Foundation

Larry Slutsker Division Director, Center for Global Health CDC

Rachel Smith Medical Epidemiologist CDC

Mark Smolinski Director, Global Health Skoll Global Threats Fund

Dan Sosin Deputy Director, Office of Public Health Preparedness and Emergency Response CDC

Lisa Splitlog Director, CDC Value Communications CDC Foundation

David Steinberg Founder and CEO CAIVIS Acquisition Corporation

Aaron Stern Trustee The Robertson Foundation

Melissa Stevens Deputy Executive Director FasterCures

Charles Stokes President and CEO CDC Foundation

Linda Streitfeld Director of Programs National Press Foundation

Jerry Stubenhofer Chief Legal Officer, Senior Vice President and Secretary GNC Holdings Inc.

Burt Sugarman CEO Giant Group, Ltd.

Jordan Tappero Director, Division of Global Health Protection CDC

43

PARTICIPANTS

Beverly Daniel Tatum President Spelman College

Ara Tavitian Principal Kanon Ventures

Alan Tennenberg Vice President, Global Health Johnson & Johnson Services Inc.

Peter Thoren Executive Vice President Access Industries

Ken Thorpe Robert W. Woodruff Professor and Chair of the Department of Health Policy and Management Emory University

Jack Tillman Executive Director, Emory Innovations Emory University

Chloe Tonney Senior Vice President of External Affairs CDC Foundation

Mark Tykocinski Dean Jefferson Medical College

Richard Umbdenstock President and CEO American Hospital Association

Ellen Urbanski Assistant Vice President George Washington University

Carmen Villar Chief of Staff CDC

Ted Virtue CEO MidOcean Partners

Paul Volberding Director, AIDS Research Institute; Director of Research, Global Health Science University of California, San Francisco

Andrew von Eschenbach President Samaritan Health Initiatives Former Commissioner U.S. Food and Drug Administration Former Director National Cancer Institute

Deborah Von Zinkernagel U.S. Global AIDS Coordinator (Acting) U.S. Department of State

Larry Weisenberg Director of Communications Knowledge Universe

Harlan Weisman Managing Director And-One Consulting LLC

Alex White Global Head, Infectious Diseases, Immunology and Ophthalmology F. Hoffmann-La Roche Ltd.

André Williams CEO Association of Black Cardiologists

Eustace Wolfington President Cabrini Asset Management

Bob Yellowlees Chairman, Retired Global Payments, Inc./NDC Health

Kneeland Youngblood Founding Partner Pharos Capital Group, LLC

Steve Zatz President WebMD

Catherine Zilber Senior Program Officer CDC Foundation

44

ACKNOWLEDGMENTS

The idea for this Summit came from a simple conversation

in Los Angeles last spring between Dr. Tom Frieden

and Mike Milken. The two had just stepped offstage

following a conference panel, and they floated the idea

of convening leaders from government, private industry,

universities and philanthropies on the CDC campus.

Charles Stokes, president of the CDC Foundation,

offered to co-host the event.

Since that time, all three organizations have worked

tirelessly to turn that idea into a reality.

The Milken Institute and CDC Foundation wish to

thank the many individuals – from senior leaders

to junior staffers – whose hard work, dedication and

persistence made this event possible.

We also thank the men and women of CDC.

Your commitment to public service, though too

often unrecognized, protects us all.

CONFERENCEGLOBAL

2014

APRIL 27-30

MILKEN INSTITUTE

BEVERLY HILTONLOS ANGELESwww.globalconference.org

1250 Fourth StreetSanta Monica, CA 90401Phone: 310-570-4600

1101 New York Avenue NW, Suite 620Washington, DC 20005Phone: 202-336-8930

www.milkeninstitute.org

55 Park Place NE Suite 400Atlanta, Georgia 30303Phone: 404-653-0790

www.cdcfoundation.org

download the program - milken institute

Documents